Eurofins
- Revenue€5.4 BFY, 2020
- Market Capitalization€15.6 B2022-05-12
OverviewSuggest Edit
Eurofins Scientific is a life sciences company providing laboratory testing services. It offers food, environmental, pharmaceutical, and cosmetic product testing, as well as agroscience contract research organization (CRO) services. The company also provides testing and laboratory services for genomics, discovery pharmacology, forensics, contract development and manufacturing organization (CDMO), advanced material sciences, etc.
| Type | Public | |
| Founded | 1987 | |
| HQ | Luxembourg, LU | Map |
| Website | eurofins.com | |
| Employee Ratings | ||
| Overall Culture | B- | More |
Recent NewsAll News
- Eurofins Viracor and Cornell University Sign Exclusive Licensing Agreement to Expand Access to Ground-Breaking Technologies for Assessing Organ and Tissue Damage in Transplant and COVID-19 Patients
- Europe Markets: COVID-19 testing demand sends Eurofins into top French stock market index
- Covid Test Maker Eurofins To Replace Atos in France’s CAC 40
- Eurofins DQCI partners with Southeast Milk at Florida site
Key People/Management at Eurofins
Gilles G. Martin
Founder, Chairman & CEO
Christian Wurst
Chief Operating Officer, Food & Environment Testing
Mathilde Latreille
Head of Clinical Trials Early Development.
Yves-Loïc Martin
Executive Director
Valérie Hanote
Executive Director
Laurent Lebras
Group Finance & Administration Director
Eurofins Office Locations
Eurofins has offices in Luxembourg, Alachua, Arvada, Austin and in 608 other locations
Luxembourg, LU (HQ)
23 Val Fleuri
Luxembourg, LU
10a Rue Henri M. Schnadt
Suzhou, CN
Huqiu District
Aix-en-Provence, FR
105 Avenue de Bredasque
Aix-en-Provence, FR
1bis Rue Aude
Aix-en-Provence, FR
210 Avenue du Grand Vallat
Eurofins Financials and Metrics
Eurofins Revenue
Eurofins's revenue was reported to be €5.44 b in FY, 2020 which is a 19.2% increase from the previous period.
| EUR | |
|---|---|
Revenue (H1, 2021) | 3.3b |
Net income (H1, 2021) | 415.9m |
EBITDA (H1, 2021) | 989.1m |
EBIT (H1, 2021) | 724.6m |
Market capitalization (12-May-2022) | 15.6b |
Closing stock price (12-May-2022) | 81.2 |
Cash (30-Jun-2021) | 639.9m |
EV | 17.6b |
Eurofins's current market capitalization is €15.6 b.
Annual
| EUR | FY, 2018 |
|---|---|
Revenue/Employee | 106.5k |
Debt/Equity | 1.2 x |
Debt/Assets | 0.4 x |
Financial Leverage | 2.6 x |
Eurofins Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Lab Solution | July 11, 2019 | |
| Transplant Genomics Inc. | June 25, 2019 | |
| Chemtest Limited | April 11, 2019 | |
| EnvironeX Group | October 31, 2018 | |
| TestAmerica Laboratories | October 31, 2018 | |
| Laboratoire Dermscan | October 29, 2018 | |
| Clinical Research Laboratories | September 04, 2018 | |
| Eurofins Nanolab Technologies | August 02, 2018 | |
| Covance Food Solutions | August 01, 2018 | |
| Laboratorios Ecosur | July 27, 2018 |
Eurofins Revenue Breakdown
Eurofins revenue breakdown by business segment: 5.9% from Study-Based Business, 88.0% from Sample-Based usiness and 6.1% from Other
Eurofins revenue breakdown by geographic segment: 7.5% from Rest of the World, 57.8% from Europe and 34.7% from North America
Eurofins Cybersecurity Score
Eurofins Environment, Social & Governance (ESG) Ratings
Eurofins Online and Social Media Presence
408 Twitter followers
Eurofins has 408 Twitter Followers. The number of followers has increased 0.5% month over month and increased 3.8% quarter over quarter
Eurofins's Trends
Eurofins Company Culture
Overall Culture
B-
69/100
CEO Rating
B-
70/100
Compensation
C-
60/100
Diversity
A+
84/100
Eurofins News and Updates
March 17, 2022
Eurofins Viracor and Cornell University Sign Exclusive Licensing Agreement to Expand Access to Ground-Breaking Technologies for Assessing Organ and Tissue Damage in Transplant and COVID-19 Patients
Blood and urine-based cell-free DNA detection methods will provide healthcare practitioners with highly accurate, non-invasive tools to identify and monitor for infection, rejection, and severity of organ damage in transplant and COVID-19 patients LEE'S SUMMIT, Mo., March 17, 2022...
September 10, 2021
Europe Markets: COVID-19 testing demand sends Eurofins into top French stock market index
Laboratory testing services group Eurofins Scientific is set to join France's top stock market index, buoyed by demand for COVID-19 testing.
September 10, 2021
Covid Test Maker Eurofins To Replace Atos in France’s CAC 40
Covid Test Maker Eurofins To Replace Atos in France’s CAC 40
September 07, 2021
Eurofins DQCI partners with Southeast Milk at Florida site
Dairy laboratory service company Eurofins DQCI is partnering with US dairy cooperative Southeast Milk, Inc. to assume operational responsibility of the Belleview, Florida site.Dairy laboratory service company Eurofins DQCI is partnering with US dairy cooperative Southeast Milk, Inc. to assume operat…
August 24, 2021
Fusion Antibodies teams up with Eurofins Discovery to provide antibody development services
StockMarketWire.com - Antibody engineering and supplier Fusion Antibodies said it had entered into a commercial collaboration agreement with Eurofins Discovery, a provider if products and services to the drug discovery industry.
August 12, 2021
Eurofins Expands Its Network of COVID-19 Testing Centers, Including Airports, Ports, Train Stations and Drive-Through Testing Centers, to Enable Convenient and Safe International Travel
As international travel for leisure and business continues to gather momentum, easy access to reliable and cost-effective testing is paramount to ensure safe and hassle-free travel experiences. Alongside further vaccination levels, wide-spread testing for SARS-CoV-2 (COVID-19), and sequencing of pos…
Eurofins Frequently Asked Questions
When was Eurofins founded?
Eurofins was founded in 1987.
Who are Eurofins key executives?
Eurofins's key executives are Gilles G. Martin, Christian Wurst and Mathilde Latreille.
How many employees does Eurofins have?
Eurofins has 57,992 employees.
What is Eurofins revenue?
Latest Eurofins annual revenue is €5.4 b.
What is Eurofins revenue per employee?
Latest Eurofins revenue per employee is €93.8 k.
Who are Eurofins competitors?
Competitors of Eurofins include Catalent, Labcorp Drug Development and Charles River Laboratories.
Where is Eurofins headquarters?
Eurofins headquarters is located at 23 Val Fleuri, Luxembourg.
Where are Eurofins offices?
Eurofins has offices in Luxembourg, Alachua, Arvada, Austin and in 608 other locations.
How many offices does Eurofins have?
Eurofins has 786 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies